Loading clinical trials...
Loading clinical trials...
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of Celivarone at 50, 100 or 300 mg OD With Amiodarone as Calibrator for the Prevention of ICD Interventions or Death
Conditions
Interventions
Celivarone
Amiodarone
+1 more
Locations
151
United States
Investigational Site Number 840006
Huntsville, Alabama, United States
Investigational Site Number 840042
Mobile, Alabama, United States
Investigational Site Number 840014
Mesa, Arizona, United States
Investigational Site Number 840032
Phoenix, Arizona, United States
Investigational Site Number 840033
Tucson, Arizona, United States
Investigational Site Number 840054
Redondo Beach, California, United States
Start Date
September 1, 2009
Primary Completion Date
May 1, 2011
Completion Date
May 1, 2011
Last Updated
May 30, 2016
NCT06835491
NCT06964464
NCT06591260
NCT04394637
NCT02864771
NCT06940752
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions